Filing Details

Accession Number:
0001209191-23-010204
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-16 17:37:53
Reporting Period:
2023-02-14
Accepted Time:
2023-02-16 17:37:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831097 Agilon Health Inc. AGL Services-Misc Health & Allied Services, Nec (8090) 371915147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1855842 Benjamin Kornitzer C/O Agilon Health, Inc.
6210 E Hwy 290, Suite 450
Austin TX 78723
Chief Med. & Quality Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-14 25,881 $8.99 36,307 No 4 M Direct
Common Stock Disposition 2023-02-14 25,881 $22.99 10,426 No 4 S Direct
Common Stock Acquisiton 2023-02-15 8,094 $8.99 18,520 No 4 M Direct
Common Stock Disposition 2023-02-15 8,094 $22.98 10,426 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options (Rights to Buy) Disposition 2023-02-14 25,881 $0.00 25,881 $8.99
Common Stock Options (Rights to Buy) Disposition 2023-02-15 8,094 $0.00 8,094 $8.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
165,470 2030-01-31 No 4 M Direct
157,376 2030-01-31 No 4 M Direct
Footnotes
  1. Includes restricted stock units.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.66 to $23.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.89 to $23.125, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  5. These options were granted on January 31, 2020 and vested on September 14, 2021.